진세노사이드 Rg3 또는 진세노사이드 Rh2를포함하는 글루타메이트 매개 신경독성 억제 조성물
    3.
    发明公开
    진세노사이드 Rg3 또는 진세노사이드 Rh2를포함하는 글루타메이트 매개 신경독성 억제 조성물 无效
    用于抑制含有GINSENOSIDE RG3或GINSENOSIDE RH2的谷氨酸介导的神经毒性的组合物

    公开(公告)号:KR1020040036451A

    公开(公告)日:2004-04-30

    申请号:KR1020020065648

    申请日:2002-10-26

    Inventor: 임혜원 김선오

    CPC classification number: A61K31/7048 A61K2300/00

    Abstract: PURPOSE: Provided is a composition for inhibiting glutamate-mediated neurotoxicity comprising ginsenoside Rg3 or ginsenoside Rh2. The composition has excellent neurotoxicity inhibiting effect or nerve cells protection effect, and is thus effective for treatment of brain diseases, such as Alzheimer's disease, Huntington's disease, epilepsy, stroke, cerebral paralysis and the like. CONSTITUTION: A composition for inhibiting glutamate-mediated neurotoxicity is characterized by containing 20(S)- ginsenosideRg3 or its metabolite, 20(S)-ginsenoside Rh2 which have excellent inhibition effect on an NMDA receptor. Therefore, it is used for treatment of brain diseases, such as Alzheimer's disease, Huntington's disease, epilepsy, stroke, cerebral paralysis and the like.

    Abstract translation: 目的:提供一种抑制谷氨酸介导的神经毒性的组合物,包括人参皂甙Rg3或人参皂甙Rh2。 该组合物具有优异的神经毒性抑制作用或神经细胞保护作用,因此有效治疗诸如阿尔茨海默病,亨廷顿病,癫痫,中风,脑麻痹等脑疾病。 构成:用于抑制谷氨酸介导的神经毒性的组合物的特征在于含有对NMDA受体具有优异抑制作用的20(S) - 人参皂苷Rg3或其代谢物,20(S) - 人参皂甙Rh2。 因此,其用于治疗脑疾病,例如阿尔茨海默病,亨廷顿病,癫痫,中风,脑麻痹等。

Patent Agency Ranking